Cargando…

Economic evaluation of human papillomavirus vaccination in the United Kingdom

Objective To assess the cost effectiveness of routine vaccination of 12 year old schoolgirls against human papillomavirus infection in the United Kingdom. Design Economic evaluation. Setting UK. Population Schoolgirls aged 12 or older. Main outcome measures Costs, quality adjusted life years (QALYs)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jit, Mark, Choi, Yoon Hong, Edmunds, W John
Formato:	Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group Ltd. 2008
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2500202/ https://www.ncbi.nlm.nih.gov/pubmed/18640957 http://dx.doi.org/10.1136/bmj.a769

Ejemplares similares

Comparing bivalent and quadrivalent human papillomavirus vaccines: economic evaluation based on transmission model
por: Jit, Mark, et al.
Publicado: (2011)

How to Prevent Vaccines Falling Victim to Their Own Success: Intertemporal Dependency of Incidence Levels on Indirect Effects in Economic Reevaluations
por: Sandmann, Frank, et al.
Publicado: (2021)

Impact and Cost-effectiveness of Selective Human Papillomavirus Vaccination of Men Who Have Sex With Men
por: Lin, Allen, et al.
Publicado: (2017)

Comparison of two dose and three dose human papillomavirus vaccine schedules: cost effectiveness analysis based on transmission model
por: Jit, Mark, et al.
Publicado: (2015)

The potential health and economic value of SARS-CoV-2 vaccination alongside physical distancing in the UK: a transmission model-based future scenario analysis and economic evaluation
por: Sandmann, Frank G, et al.
Publicado: (2021)

Projected impact of Cervarix™ vaccination on oncogenic human papillomavirus infection and cervical cancer in the United Kingdom
por: Van Effelterre, Thierry P, et al.
Publicado: (2015)

Estimating number of cases and spread of coronavirus disease (COVID-19) using critical care admissions, United Kingdom, February to March 2020
por: Jit, Mark, et al.
Publicado: (2020)

Simultaneously characterizing the comparative economics of routine female adolescent nonavalent human papillomavirus (HPV) vaccination and assortativity of sexual mixing in Hong Kong Chinese: a modeling analysis
por: Choi, Horace C. W., et al.
Publicado: (2018)

The framework of regional economics in the United Kingdom /
por: Brown, A. J. (Alfred John), 1893-1976
Publicado: (1972)

The impact of vaccination on gender equity: conceptual framework and human papillomavirus (HPV) vaccine case study
por: Portnoy, Allison, et al.
Publicado: (2020)

Oral Human Papillomavirus Infection in Men Who Have Sex with Men: A Systematic Review and Meta-Analysis
por: King, Eleanor M., et al.
Publicado: (2016)

Cost-effectiveness of Human Papillomavirus Vaccination in the United States
por: Chesson, Harrell W., et al.
Publicado: (2008)

Human papillomavirus DNA in men who have sex with men: type-specific prevalence, risk factors and implications for vaccination strategies
por: King, E M, et al.
Publicado: (2015)

Oral human papillomavirus (HPV) infection in men who have sex with men: prevalence and lack of anogenital concordance
por: King, Eleanor M, et al.
Publicado: (2015)

A review of typhoid fever transmission dynamic models and economic evaluations of vaccination
por: Watson, Conall H., et al.
Publicado: (2015)

Informing Global Cost-Effectiveness Thresholds Using Country Investment Decisions: Human Papillomavirus Vaccine Introductions in 2006-2018
por: Jit, Mark
Publicado: (2021)

Costs of delivering human papillomavirus vaccination to schoolgirls in Mwanza Region, Tanzania
por: Quentin, Wilm, et al.
Publicado: (2012)

Assessing the value of human papillomavirus vaccination in Gavi-eligible low-income and middle-income countries
por: Ochalek, Jessica, et al.
Publicado: (2020)

Methodological Challenges to Economic Evaluations of Vaccines: Is a Common Approach Still Possible?
por: Jit, Mark, et al.
Publicado: (2016)

Evaluating Human Papillomavirus Vaccination Programs
por: Taira, Al V., et al.
Publicado: (2004)

The epidemiologic and economic impact of a quadrivalent human papillomavirus vaccine in Thailand
por: Termrungruanglert, Wichai, et al.
Publicado: (2021)

Health and the 2008 Economic Recession: Evidence from the United Kingdom
por: Astell-Burt, Thomas, et al.
Publicado: (2013)

Economic Cost of Campylobacter, Norovirus and Rotavirus Disease in the United Kingdom
por: Tam, Clarence C, et al.
Publicado: (2016)

Understanding and modelling the economic impact of spinal cord injuries in the United Kingdom
por: McDaid, David, et al.
Publicado: (2019)

Cervical cancer treatment costs and cost-effectiveness analysis of human papillomavirus vaccination in Vietnam: a PRIME modeling study
por: Van Minh, Hoang, et al.
Publicado: (2017)

Projections of human papillomavirus (HPV) vaccination impact in Ethiopia, India, Nigeria and Pakistan: a comparative modelling study
por: Portnoy, Allison, et al.
Publicado: (2021)

The epidemiological and economic impact of a quadrivalent human papillomavirus (hpv) vaccine in Estonia
por: Uusküla, Anneli, et al.
Publicado: (2013)

Assessing the Health and Economic Outcomes of a 9-Valent HPV Vaccination Program in the United Kingdom
por: Owusu-Edusei, Kwame, et al.
Publicado: (2022)

Potential lives saved in 73 countries by adopting multi‐cohort vaccination of 9–14‐year‐old girls against human papillomavirus
por: Jit, Mark, et al.
Publicado: (2018)

Health economic evaluation of Human Papillomavirus vaccines in women from Venezuela by a lifetime Markov cohort model
por: Bardach, Ariel Esteban, et al.
Publicado: (2017)

Understanding chemotherapy treatment pathways of advanced colorectal cancer patients to inform an economic evaluation in the United Kingdom
por: Shabaruddin, F H, et al.
Publicado: (2010)

Risk of new onset autoimmune disease in 9- to 25-year-old women exposed to human papillomavirus-16/18 AS04-adjuvanted vaccine in the United Kingdom
por: Willame, Corinne, et al.
Publicado: (2016)

Avoidable costs of stenting for aortic coarctation in the United Kingdom: an economic model
por: Salcher, Maximilian, et al.
Publicado: (2017)

From cervical cancer elimination to eradication of vaccine-type human papillomavirus: Feasibility, public health strategies and cost-effectiveness
por: Jit, Mark, et al.
Publicado: (2021)

Determinants of shingles vaccine acceptance in the United Kingdom
por: Bricout, Hélène, et al.
Publicado: (2019)

Global impact and cost-effectiveness of one-dose versus two-dose human papillomavirus vaccination schedules: a comparative modelling analysis
por: Prem, Kiesha, et al.
Publicado: (2023)

An Economic Comparison of Influenza Vaccines Recommended for Use in Eligible Adults under 65 Years in the United Kingdom
por: Maschio, Michael, et al.
Publicado: (2022)

MCDA from a health economics perspective: opportunities and pitfalls of extending economic evaluation to incorporate broader outcomes
por: Jit, Mark
Publicado: (2018)

Costing the COVID-19 Pandemic: An Exploratory Economic Evaluation of Hypothetical Suppression Policy in the United Kingdom
por: Zala, Darshan, et al.
Publicado: (2020)

Human papillomavirus vaccine introduction in low-income and middle-income countries: guidance on the use of cost-effectiveness models
por: Jit, Mark, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_l18n9dsqq3cv6b9rkd6ddlh3ef